TRAF3IP2 as a novel inflammatory biomarker for coronary artery disease: development and validation of a multimodal prediction model
In summary, this study demonstrated that TRAF3IP2 could be a potential biomarker for CAD. A nomogram composed of sex, diabetes history, phosphoremia, and TRAF3IP2 expression may predict the risk of CAD.
Authors
- Yang Gu (ORCID: https://orcid.org/0000-0001-6984-3653)
- Tingting Hu (ORCID: https://orcid.org/0009-0002-6181-3075)
- Qiuyao Du (ORCID: https://orcid.org/0000-0002-1495-2024)
- Jin Geng (ORCID: https://orcid.org/0000-0001-9336-9349)
- Peibing Ge
- Mengjie Liu (ORCID: https://orcid.org/0000-0001-7823-1851)
- Tianyi Ni (ORCID: https://orcid.org/0000-0001-6460-4047)
- Changjiang Xu
- Hailang Liu
Institutions
- Huaian First People’s Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-10-20
- DOI
- https://doi.org/10.3389/fendo.2025.1644403
- Citations
- 1
- Primary Topic
- Atherosclerosis and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.80